/Investor DB

Nihon PMI Partners

Private equity

Growth–Late Stage · 37 people tracked

Find your way into Nihon PMI Partners

Sign up to see every warm intro you have to Nihon PMI Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nihon PMI Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Nihon PMI Partners invests in Japan's healthcare and nursing-care industry, aiming to drive change in medicine through the power of investment and create a society where people do not struggle to access care. It targets unlisted companies serving hospitals and home-care providers, focusing on business succession support. Addressing challenges such as inefficient operation by SMEs, regional disparities, successor shortages, and an aging population, the firm uses M&A and post-merger integration expertise to maximize synergies and accelerate transformation. Its members leverage healthcare domain knowledge and networks, strengthen management teams, craft growth strategies, and provide capital and resources, while promoting DX for efficiency and new business creation.

Source: firm website, verified Oct 2, 2026.

Stage
Growth–Late Stage
Instruments
Equity

Team · 37 people

from the firm's website
Satoshi Hamada· CEO

CEO of the firm; holds an MBA.

Ko Sato· Managing Director

Managing Director; holds an LL.M.

Masanori Shoji· Executive Director

Executive Director; holds an MBA.

Seiichi Ohara· Managing Director

Managing Director; holds an MBA.

Takaaki Sakai· Executive Director

Executive Director with management and IPO experience.

Tomoyuki Nakajima· Managing Director

Managing Director; holds an MBA and CFA/CMA qualifications.

Megumi Kawamoto· Director

Director; holds an M.D.

Yoshitaka Doi· Director

Director; holds an M.D.

Hatsuhi Numagami· Associate

Associate at the firm.

Jin Yinzhu· Associate

Associate at the firm.

Makoto Kuroda· Compliance Officer

Serves as Compliance Officer at the firm.

Masaki Sugita· Advisor

Director at KKR Capital Markets and formerly Managing Director at UBS Asset Management.

Mika Ikawa· Manager

Manager at the firm.

Sana Kurimata· Associate

Associate at the firm.

Shota Hanamiya· Manager

Manager at the firm.

Shota Miyazaki· Associate

Associate at the firm.

Taichi Yamaguchi· Advisor

Representative Director at AICRO; previously at Kirin Karute and Recruit.

Takahiro Shimada· Senior Associate

Senior Associate at the firm.

Yasuko Maekawa· Executive Secretary to CEO

Executive Secretary to the CEO.

Yuki Nemoto· Senior Associate

Senior Associate at the firm.

Yuta Takagi· Senior Associate

Senior Associate at the firm.

Frequently asked questions

What stage does Nihon PMI Partners invest at?
Nihon PMI Partners invests at the Growth, Late Stage stages.
What sectors does Nihon PMI Partners focus on?
Nihon PMI Partners focuses on Digital Health, Healthtech, Medical Devices, Sector Agnostic.

Images

Nihon PMI Partners photo

Similar investors

Featured in lists